New SEC Form D filing

Typewriter Therapeutics, Inc., 2026-09-21

A new SEC Form D private-offering notice from Cambridge, MA, a $56,299,999 filer-stated offering target in Biotech. The source filing is one click away.

What this filing says

Typewriter Therapeutics, Inc. site↗ Verified via SEC Form D

Develops all-RNA genetic medicines using RNA-delivered gene insertion technology for in vivo CAR-T and liver-targeted therapies

Filed 2026-09-21Filed to raise $56,299,999First money in 2026-01-08Raised so far $56,299,999HQ (as filed) Cambridge, MASector Biotech web-verified against the company’s own siteStage (inferred) GrowthCall status Late filing
Source linked the Form D on EDGAR↗Website verified typewritertx.com↗Named in the filing 4 executives & directors
Open this row on the live feed →More new filings in Massachusetts →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source